Home > News > DermAvance Acquires Hyalogy(TM)
August 16th, 2006
DermAvance Acquires Hyalogy(TM)
Abstract:
DermAvance Pharmaceuticals, a privately held pharmaceutical company specializing in advanced technology
applications for skin health and cosmetic dermatology, today announced the acquisition of the North American rights for the Hyalogy(TM) Total Skin Care Line from Forlle'd in Japan.
Source:
prnewswire
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Personal Care/Cosmetics
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
A Comprehensive Guide: The Future of Nanotechnology September 13th, 2018
Graphene finds new application as anti-static hair dye: New formula works as well as commercial permanent dyes without chemically altering hairs March 22nd, 2018
Programmable materials find strength in molecular repetition May 23rd, 2016
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||